PT2539328E - Derivados de furoxano solúveis em água com uma atividade antitumoral - Google Patents

Derivados de furoxano solúveis em água com uma atividade antitumoral Download PDF

Info

Publication number
PT2539328E
PT2539328E PT117116665T PT11711666T PT2539328E PT 2539328 E PT2539328 E PT 2539328E PT 117116665 T PT117116665 T PT 117116665T PT 11711666 T PT11711666 T PT 11711666T PT 2539328 E PT2539328 E PT 2539328E
Authority
PT
Portugal
Prior art keywords
water soluble
antitumor activity
furoxan
derivatives
furoxan derivatives
Prior art date
Application number
PT117116665T
Other languages
English (en)
Inventor
Antonella Viola
Enzo Bronte
Marco Crosetti
Loretta Lazzarato
Roberta Fruttero
Alberto Gasco
Original Assignee
Istituto Oncologico Veneto Irccs
Humanitas Mirasole Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Oncologico Veneto Irccs, Humanitas Mirasole Spa filed Critical Istituto Oncologico Veneto Irccs
Publication of PT2539328E publication Critical patent/PT2539328E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/081,2,5-Oxadiazoles; Hydrogenated 1,2,5-oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245Oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT117116665T 2010-02-23 2011-02-23 Derivados de furoxano solúveis em água com uma atividade antitumoral PT2539328E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2010A000287A IT1398522B1 (it) 2010-02-23 2010-02-23 Nuovi derivati furossanici idrosolubili aventi attivita' antitumorale.

Publications (1)

Publication Number Publication Date
PT2539328E true PT2539328E (pt) 2014-11-05

Family

ID=42676615

Family Applications (1)

Application Number Title Priority Date Filing Date
PT117116665T PT2539328E (pt) 2010-02-23 2011-02-23 Derivados de furoxano solúveis em água com uma atividade antitumoral

Country Status (7)

Country Link
US (1) US8946271B2 (pt)
EP (1) EP2539328B1 (pt)
DK (1) DK2539328T3 (pt)
ES (1) ES2522841T3 (pt)
IT (1) IT1398522B1 (pt)
PT (1) PT2539328E (pt)
WO (1) WO2011104671A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013271378A1 (en) 2012-06-07 2014-12-18 Beth Israel Deaconess Medical Center, Inc. Methods and compositions for the inhibition of Pin1
WO2016011265A2 (en) 2014-07-17 2016-01-21 Beth Israel Deaconess Medical Center, Inc. Biomarkers for pin1-associated disorders
WO2016145186A1 (en) 2015-03-12 2016-09-15 Beth Israel Deaconess Medical Center, Inc. Enhanced atra-related compounds for the treatment of proliferative diseases, autoimmune diseases, and addiction conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE485261T1 (de) * 2005-11-23 2010-11-15 Nicox Sa Salicylsäurederivate
WO2010081488A1 (en) * 2009-01-15 2010-07-22 Humanitas Mirasole S.P.A. Nitric oxide furoxan derivative compounds endowed with antitumoral activity

Also Published As

Publication number Publication date
EP2539328A1 (en) 2013-01-02
US8946271B2 (en) 2015-02-03
DK2539328T3 (da) 2014-11-03
ITMI20100287A1 (it) 2011-08-24
WO2011104671A1 (en) 2011-09-01
IT1398522B1 (it) 2013-03-01
US20130035360A1 (en) 2013-02-07
EP2539328B1 (en) 2014-07-30
ES2522841T3 (es) 2014-11-18

Similar Documents

Publication Publication Date Title
HUS2300018I1 (hu) Rákellenes hatású kinoli-8-szulfonamid-származékok
IL237581B (en) Derivatives of 6-oxo-pyrazinopyrrolopyrimidines
HK1182594A1 (en) N3-substituted-n1-sulfonyl-5-fluoropyrimidinone derivatives n3--n1--5-
HK1179607A1 (en) Arylethynyl derivatives
HK1172893A1 (en) 5-fluoropyrimidinone derivatives 5-
ZA201209117B (en) Tetrahydro-pyrido-pyrimidine derivatives
EP2462134A4 (en) N1-SULFONYL-5-FLUOROPYRIMIDINONE DERIVATIVES
IL219029A0 (en) Pyrazolopyrimidine derivatives
HK1169623A1 (en) Pyrazinooxazepine derivatives
EP2519512A4 (en) The present invention relates to the field of N1-acyl-5-fluoropyrimidinones and their derivatives and the use of its compounds as fungicides
HK1163663A1 (en) Rifamycin derivatives
IL219603A0 (en) Imidazopyridine derivatives
EP2485721A4 (en) APOGOSSYPOLONE DERIVATIVES AS ANTICANCER AGENTS
GB2490849B (en) Di-aspirin derivatives
HK1174625A1 (en) Pyrrazolopyridine derivatives
PT2539328E (pt) Derivados de furoxano solúveis em água com uma atividade antitumoral
HU1000243D0 (en) 8-hidroxy-quinoline derivatives
EP2512482A4 (en) DERIVATIVES OF 2-ALDOXIMINO-5-FLUOROPYRIMIDINE
GB0918924D0 (en) Azaindole derivatives
GB0912499D0 (en) Indopyl-pyridone derivatives
ZA201209248B (en) Amido-tropane derivatives
IL220983A0 (en) 2-aldoximino-5-fluoropyrimidine derivatives